We are live on ! Find out more
EC

EntryPoint Capital Portfolio holdings

AUM $341M
1-Year Est. Return 20.57%
This Fund
S&P 500
This Quarter Est. Return
+8.02%
1 Year Est. Return
+20.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$176M
AUM Growth
+$107M
Cap. Flow
+$103M
Cap. Flow %
58.75%
Top 10 Hldgs %
4.24%
Holding
1,234
New
413
Increased
180
Reduced
1
Closed
640

Top Buys

Rank Stock Value
1
GH icon
Guardant Health
GH
+$895K
2
PLAB icon
Photronics
PLAB
+$774K
3
EW icon
Edwards Lifesciences
EW
+$755K
4
MMS icon
Maximus
MMS
+$754K
5
TTEK icon
Tetra Tech
TTEK
+$745K

Top Sells

Rank Stock Value
1
DK icon
Delek US
DK
+$197K
2
CSGP icon
CoStar Group
CSGP
+$197K
3
VIST icon
Vista Energy
VIST
+$197K
4
SKX
Skechers
SKX
+$196K
5
ALRS icon
Alerus Financial
ALRS
+$195K

Sector Composition

Rank Sector Weight
1 Healthcare 19.45%
2 Technology 17.59%
3 Industrials 17.43%
4 Consumer Discretionary 12.31%
5 Financials 10.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PR
1026
Permian Resources
PR
$17.9B
– –
-8,749
Closed -$141K
PRA
1027
DELISTED
ProAssurance
PRA
– –
-2,392
Closed -$29.2K
PRI icon
1028
Primerica
PRI
$9.81B
– –
-426
Closed -$101K
PRVA icon
1029
Privia Health
PRVA
$3.21B
– –
-7,420
Closed -$129K
PSO icon
1030
Pearson
PSO
$9.78B
– –
-2,306
Closed -$28.8K
PTLO icon
1031
Portillo's
PTLO
$315M
– –
-750
Closed -$7.29K
PYPL icon
1032
PayPal
PYPL
$49.5B
– –
-2,579
Closed -$150K
PZZA icon
1033
Papa John's
PZZA
$999M
– –
-2,433
Closed -$114K
QFIN icon
1034
Qfin Holdings
QFIN
$1.61B
– –
-1,540
Closed -$30.4K
QLYS icon
1035
Qualys
QLYS
$4.84B
– –
-742
Closed -$106K
RAMP icon
1036
LiveRamp
RAMP
$2.29B
– –
-6,296
Closed -$195K
RARE icon
1037
Ultragenyx Pharmaceutical
RARE
$2.65B
– –
-2,531
Closed -$104K
RBCAA icon
1038
Republic Bancorp
RBCAA
$1.84B
– –
-3,271
Closed -$175K
RDW icon
1039
Redwire
RDW
$2.08B
– –
-34
Closed -$244
RELY icon
1040
Remitly
RELY
$4.74B
– –
-2,734
Closed -$33.1K
REPL icon
1041
Replimune Group
REPL
$814M
– –
-8,051
Closed -$72.5K
REYN icon
1042
Reynolds Consumer Products
REYN
$5.4B
– –
-472
Closed -$13.2K
REZI icon
1043
Resideo Technologies
REZI
$5.23B
– –
-1,909
Closed -$37.3K
RF icon
1044
Regions Financial
RF
$26.3B
– –
-5,001
Closed -$100K
RGA icon
1045
Reinsurance Group of America
RGA
$15.7B
– –
-635
Closed -$130K
RGLD icon
1046
Royal Gold
RGLD
$17.1B
– –
-1,109
Closed -$139K
RHI icon
1047
Robert Half
RHI
$3.61B
– –
-2,838
Closed -$182K
RHP icon
1048
Ryman Hospitality Properties
RHP
$8.4B
– –
-1,591
Closed -$159K
RIVN icon
1049
Rivian
RIVN
$22.9B
– –
-1,789
Closed -$24K
RLI icon
1050
RLI Corp
RLI
$5.68B
– –
-86
Closed -$6.05K
40 41
42
43 44

Similar funds

SFA
Seneca Financial Advisors Rochester, New York $341M AUM 14.73% 1-Year Est. Return
FCM
Findell Capital Management New York $341M AUM 135.6% 1-Year Est. Return
CPI
Crestview Partners II New York $341M AUM 17.29% 1-Year Est. Return
SW
SMART Wealth Omaha, Nebraska $341M AUM 24.37% 1-Year Est. Return
MTIC
Missouri Trust & Investment Company Springfield, Missouri $341M AUM 17.31% 1-Year Est. Return
KFSC
Keystone Financial Services (Colorado) Loveland, Colorado $341M AUM 18.11% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
SC
Slotnik Capital Dallas, Texas $342M AUM 105.92% 1-Year Est. Return

EntryPoint Capital's Q3 2024 Portfolio in Review

As of Q3 2024, EntryPoint Capital held 1,234 positions worth $176M, up 157% from $68.4M the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.

EntryPoint Capital deployed $103M of net new capital in Q3 2024, opening 413 new positions and adding to 180 existing holdings. Its largest new stake was Guardant Health: 31,633 shares worth $726K.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iRadimed, an estimated $8.4K trimmed.

  • EntryPoint Capital's largest Q3 2024 buy was Guardant Health: 31,633 shares worth $726K.
  • EntryPoint Capital added most to Edwards Lifesciences in Q3 2024, an estimated $755K increase.
  • EntryPoint Capital's biggest Q3 2024 reduction was iRadimed, cutting an estimated $8.4K.
  • EntryPoint Capital fully exited Delek US in Q3 2024, selling an estimated $197K.
  • EntryPoint Capital's ten largest holdings make up 4.2% of its $176M portfolio in Q3 2024.
  • EntryPoint Capital opened 413 new positions and closed 640 in Q3 2024.
  • EntryPoint Capital's portfolio value rose 157% quarter-over-quarter to $176M.

Based on EntryPoint Capital's 13F filing for Q3 2024, filed 13 Nov 2024.